-
Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
-
Advancing Germline Genetic Testing for Breast Cancer in Resource-Restricted Settings: Evidence, Barriers, and a Practical Roadmap for Implementation
-
Watch and Wait Strategy for Locally Advanced Rectal Cancer: Update From Results of Recent Clinical Trials
-
Perspectives and Experiences of Individuals Undergoing Predictive Testing for Hereditary Breast and Ovarian Cancer (HBOC) Syndrome in the Western Cape, South Africa.
-
Advances in the Treatment of Breast Cancer at Different Stages of Pregnancy
-
Correction to: Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence
-
lncRNA HOTAIR in Cancer: Recent Advances and Critical Perspectives on Molecular Mechanisms
-
Intelligent nano‐platforms in breast cancer therapy: Current advances and future perspectives
-
Clinical Efficacy and Security Analysis of CDK4/6 Inhibitors Combined with ET in Patients with HR+HER2− Advanced Breast Cancer
-
Molecular and genomic advances in breast cancer: A comprehensive review of predictive and therapeutic innovations
-
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer
-
Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence
-
HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
-
Oophorectomy‐Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity
-
RAP80 Expression in Breast Cancer and Its Relationship with Apoptosis in Breast Cancer Cells [Retraction]
-
Genetic testing for cancer predisposition syndromes in pediatric cancer patients: current practices and recommendations - a systematic review
-
A comprehensive Sustainable Development Goal‐guided framework for advancing survivorship, rehabilitation, and quality of life in breast cancer patients
-
Genetic Correlation of miR-423 Polymorphism rs8067576 with Progression and Prognosis of Triple-Negative Breast Cancer
-
Salidroside-Based Nanomedicines for Triple-Negative Breast Cancer: From Molecular Mechanisms to Clinical Translation
-
Management of malignant bowel obstruction in patients with advanced cancer at the end of life
-
Liquid biopsy‐based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis
-
CEACAM1 participation in breast cancer progression
-
Design and Usability Evaluation of a Smartphone Application for Postoperative Self‐Management in Breast Cancer Patients
-
When “CAM” is not CAM: Interpreting national cancer database analyses in breast cancer
